Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections

NCT03814616 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria,Falciparum

Interventions

DRUG: Pyronaridine tetraphosphate 180mg:artesunate 60mg

Sponsor

Shin Poong Pharmaceutical Co. Ltd.

Collaborators

[object Object]